FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3951812018 | Eliglustat tartrate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3951813011 | Eliglustat tartrate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Eliglustat tartrate | Is a | Pyrrolidine | true | Inferred relationship | Some | ||
| Eliglustat tartrate | Is a | Ceramide glucosyltransferase inhibitor | true | Inferred relationship | Some | ||
| Eliglustat tartrate | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | Ceramide glucosyltransferase inhibitor (disposition) | true | Inferred relationship | Some | ||
| Eliglustat tartrate | This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. | Eliglustat | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Eliglustat (as eliglustat tartrate) 84 mg oral capsule | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | True | Eliglustat tartrate | Inferred relationship | Some | 1 |
This concept is not in any reference sets